DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,685,576 | +3.5% | 39,039 | +0.1% | 0.38% | +7.6% |
| Q2 2023 | $9,360,960 | -5.4% | 39,004 | -0.6% | 0.35% | -10.4% |
| Q1 2023 | $9,893,578 | -5.2% | 39,254 | -0.2% | 0.39% | -8.2% |
| Q4 2022 | $10,439,765 | +1.5% | 39,333 | -1.2% | 0.43% | -7.3% |
| Q3 2022 | $10,285,000 | +0.2% | 39,818 | -1.6% | 0.46% | +5.5% |
| Q2 2022 | $10,262,000 | -13.2% | 40,477 | +0.5% | 0.44% | -2.0% |
| Q1 2022 | $11,818,000 | -13.8% | 40,288 | -3.3% | 0.45% | -12.3% |
| Q4 2021 | $13,706,000 | +2.0% | 41,657 | -5.6% | 0.51% | -9.9% |
| Q3 2021 | $13,437,000 | +12.4% | 44,137 | -0.9% | 0.57% | +5.8% |
| Q2 2021 | $11,957,000 | +13.4% | 44,555 | -4.9% | 0.54% | +6.1% |
| Q1 2021 | $10,546,000 | -7.5% | 46,855 | -8.7% | 0.50% | -14.3% |
| Q4 2020 | $11,397,000 | -1.5% | 51,305 | -4.6% | 0.59% | -14.9% |
| Q3 2020 | $11,575,000 | +17.4% | 53,755 | -3.6% | 0.69% | +7.3% |
| Q2 2020 | $9,858,000 | +27.8% | 55,749 | +0.1% | 0.64% | +9.3% |
| Q1 2020 | $7,712,000 | -16.5% | 55,717 | -7.5% | 0.59% | +4.2% |
| Q4 2019 | $9,241,000 | +2.4% | 60,209 | -3.7% | 0.57% | -0.5% |
| Q3 2019 | $9,027,000 | +0.6% | 62,502 | -0.5% | 0.57% | -1.4% |
| Q2 2019 | $8,975,000 | +8.3% | 62,796 | +0.0% | 0.58% | +4.0% |
| Q1 2019 | $8,287,000 | +22.2% | 62,772 | -4.5% | 0.56% | +7.8% |
| Q4 2018 | $6,779,000 | -5.7% | 65,738 | -0.6% | 0.52% | +5.3% |
| Q3 2018 | $7,187,000 | +10.2% | 66,138 | +0.0% | 0.49% | +3.2% |
| Q2 2018 | $6,524,000 | -4.4% | 66,115 | -5.2% | 0.47% | -7.8% |
| Q1 2018 | $6,826,000 | +2.5% | 69,715 | -2.8% | 0.51% | +6.0% |
| Q4 2017 | $6,657,000 | +8.3% | 71,715 | +0.0% | 0.48% | +0.2% |
| Q3 2017 | $6,149,000 | +1.8% | 71,681 | +0.1% | 0.48% | -3.8% |
| Q2 2017 | $6,041,000 | +2.4% | 71,585 | +3.8% | 0.50% | -3.6% |
| Q1 2017 | $5,900,000 | +16.6% | 68,985 | +6.2% | 0.52% | +13.0% |
| Q4 2016 | $5,058,000 | +2.5% | 64,985 | +3.2% | 0.46% | -10.6% |
| Q3 2016 | $4,937,000 | -19.8% | 62,985 | +3.3% | 0.52% | -24.9% |
| Q2 2016 | $6,159,000 | +10.1% | 60,985 | +3.4% | 0.69% | +5.8% |
| Q1 2016 | $5,595,000 | +2.1% | 58,985 | 0.0% | 0.65% | -5.2% |
| Q4 2015 | $5,479,000 | +9.7% | 58,985 | +0.7% | 0.69% | +0.6% |
| Q3 2015 | $4,993,000 | +30.8% | 58,595 | +31.4% | 0.68% | +40.6% |
| Q2 2015 | $3,817,000 | -3.5% | 44,595 | -4.3% | 0.48% | -2.6% |
| Q1 2015 | $3,956,000 | -10.4% | 46,595 | -9.5% | 0.50% | -9.8% |
| Q4 2014 | $4,414,000 | +12.8% | 51,500 | 0.0% | 0.55% | +6.2% |
| Q3 2014 | $3,913,000 | -3.5% | 51,500 | 0.0% | 0.52% | -3.7% |
| Q2 2014 | $4,055,000 | +7.0% | 51,500 | +2.0% | 0.54% | +2.1% |
| Q1 2014 | $3,788,000 | -6.5% | 50,500 | -3.8% | 0.53% | -9.3% |
| Q4 2013 | $4,053,000 | +11.4% | 52,500 | 0.0% | 0.58% | +0.9% |
| Q3 2013 | $3,639,000 | +10.2% | 52,500 | +0.7% | 0.58% | +13.8% |
| Q2 2013 | $3,301,000 | – | 52,150 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |